02.03.26 -- Novo's Path To The First GLP-1 Weight Loss Pill

Explore how EU GMP Annex 11 revisions could reshape global pharmaceutical compliance, as well as strategies for navigating implementation challenges and building future-ready validation programs.

Discover three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

Pharmaceutical facilities face mounting pressure to modernize. Uncover how digital tools are transforming cleaning validation to boost compliance and audit readiness without disruption.

Whether a biotech is emerging or established, a dedicated CDMO program team offers invaluable support through effective communication, regulatory guidance, and adaptability to changing needs.

By integrating R&D and GMP teams early, developers can navigate complex formulation challenges and ensure a seamless transition from first-in-human trials to late-stage clinical manufacturing.

Companies seeking access to the Brazilian market must navigate more rigorous regulatory requirements, increased scrutiny, and heightened enforcement of good manufacturing practices.

Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

Examine a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

Space constraints and sterile integrity drive the shift toward modular, robotic manufacturing. Discover how adopting compact, automated systems reduces energy overhead and contamination risks.

As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that companies stay competitive and bring therapies to market faster by partnering with a CDMO.

As particle counting instruments evolve, opportunities to implement real-time quality control strategies arise, enabling the reliable production of high-quality drugs without excessive regulatory oversight.

Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.

Gain insight into a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.